The results showed that TCL1A+ B cells from SD patients are more likely to be enriched in hypoxia, NFAT, and TNF-alpha pathways, correlated with tumor invasion and metastasis, indicating a pro-tumoral environment (Table S3). The gene discussed is TCL1A; the disease is Salla disease.